144 related articles for article (PubMed ID: 16149069)
21. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma.
Littlewood-Evans AJ; Bilbe G; Bowler WB; Farley D; Wlodarski B; Kokubo T; Inaoka T; Sloane J; Evans DB; Gallagher JA
Cancer Res; 1997 Dec; 57(23):5386-90. PubMed ID: 9393764
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin K: a therapeutic target for bone diseases.
Zhao Q; Jia Y; Xiao Y
Biochem Biophys Res Commun; 2009 Mar; 380(4):721-3. PubMed ID: 19338743
[TBL] [Abstract][Full Text] [Related]
23. Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction.
Ainola M; Li TF; Mandelin J; Hukkanen M; Choi SJ; Salo J; Konttinen YT
Ann Rheum Dis; 2009 Mar; 68(3):427-34. PubMed ID: 18397961
[TBL] [Abstract][Full Text] [Related]
24. Expression of cathepsin K in the human embryo and fetus.
Haeckel C; Krueger S; Buehling F; Broemme D; Franke K; Schuetze A; Roese I; Roessner A
Dev Dyn; 1999 Oct; 216(2):89-95. PubMed ID: 10536050
[TBL] [Abstract][Full Text] [Related]
25. Mammalian mature osteoclasts as estrogen target cells.
Mano H; Yuasa T; Kameda T; Miyazawa K; Nakamaru Y; Shiokawa M; Mori Y; Yamada T; Miyata K; Shindo H; Azuma H; Hakeda Y; Kumegawa M
Biochem Biophys Res Commun; 1996 Jun; 223(3):637-42. PubMed ID: 8687448
[TBL] [Abstract][Full Text] [Related]
26. Effect of novel N-cyano-tetrahydro-pyridazine compounds, a class of cathepsin K inhibitors, on the bone resorptive activity of mature osteoclasts.
Kim SH; Jhon DJ; Song JH; No JS; Kang NS
Bioorg Med Chem Lett; 2008 Jul; 18(14):3988-91. PubMed ID: 18571402
[TBL] [Abstract][Full Text] [Related]
27. Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis.
Konttinen YT; Takagi M; Mandelin J; Lassus J; Salo J; Ainola M; Li TF; Virtanen I; Liljestrom M; Sakai H; Kobayashi Y; Sorsa T; Lappalainen R; Demulder A; Santavirta S
J Bone Miner Res; 2001 Oct; 16(10):1780-6. PubMed ID: 11585341
[TBL] [Abstract][Full Text] [Related]
28. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
[TBL] [Abstract][Full Text] [Related]
29. Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach.
Jiang K; Krous LC; Knowlton N; Chen Y; Frank MB; Cadwell C; Centola M; Jarvis JN
Placenta; 2009 Sep; 30(9):806-15. PubMed ID: 19616846
[TBL] [Abstract][Full Text] [Related]
30. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
31. Localisation and activity of cathepsins K and B in equine osteoclasts.
Gray AW; Davies ME; Jeffcott LB
Res Vet Sci; 2002 Apr; 72(2):95-103. PubMed ID: 12027589
[TBL] [Abstract][Full Text] [Related]
32. Localization of cathepsin K in bovine odontoclasts during deciduous tooth resorption.
Linsuwanont B; Takagi Y; Ohya K; Shimokawa H
Calcif Tissue Int; 2002 Feb; 70(2):127-33. PubMed ID: 11870419
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation.
Kamolmatyakul S; Chen W; Li YP
J Dent Res; 2001 Jan; 80(1):351-5. PubMed ID: 11269728
[TBL] [Abstract][Full Text] [Related]
34. Natural inhibitors targeting osteoclast-mediated bone resorption.
Zeng GZ; Tan NH; Hao XJ; Mu QZ; Li RT
Bioorg Med Chem Lett; 2006 Dec; 16(24):6178-80. PubMed ID: 17027271
[TBL] [Abstract][Full Text] [Related]
35. Osteoclast lineage and function.
Väänänen HK; Laitala-Leinonen T
Arch Biochem Biophys; 2008 May; 473(2):132-8. PubMed ID: 18424258
[TBL] [Abstract][Full Text] [Related]
36. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the kinetics of osteoclastogenesis in arthritic rats.
Schett G; Stolina M; Bolon B; Middleton S; Adlam M; Brown H; Zhu L; Feige U; Zack DJ
Arthritis Rheum; 2005 Oct; 52(10):3192-201. PubMed ID: 16200623
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.
Delaissé JM; Andersen TL; Engsig MT; Henriksen K; Troen T; Blavier L
Microsc Res Tech; 2003 Aug; 61(6):504-13. PubMed ID: 12879418
[TBL] [Abstract][Full Text] [Related]
39. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
40. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
Wilson SR; Peters C; Saftig P; Brömme D
J Biol Chem; 2009 Jan; 284(4):2584-92. PubMed ID: 19028686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
